A leading vaccine enters the final testing stage, an "antibody cocktail" heads into human trials, and a model predicts more deaths in the fall- Tech in Two

Catch up on the most important news today in 2 minutes or less. Get even more news you can use with the Tech in Two newsletter. Sign up here: https://www.wired.com/tt